Pharmacogenetics of cancer therapy: Getting personal

被引：99

作者：

Krynetski, EY ^{[1
]}

Evans, WE ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA

来源：

AMERICAN JOURNAL OF HUMAN GENETICS | 1998年 / 63卷 / 01期

关键词：

D O I：

10.1086/301941

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：11 / 16

页数：6

共 38 条

[1] Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-K-m catalysts of cyclophosphamide and ifosfamide activation [J].

Chang, TKH ;

Yu, L ;

Goldstein, JA ;

Waxman, DJ .

PHARMACOGENETICS, 1997, 7 (03) :211-221

[2] THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS [J].

CHOCAIR, PR ;

DULEY, JA ;

SIMMONDS, HA ;

CAMERON, JS .

TRANSPLANTATION, 1992, 53 (05) :1051-1056

[3]

Czwerwinski M, 1996, DRUG METAB DISPOS, V24, P1015

[4] FAMILIAL DEFICIENCY OF DIHYDROPYRIMIDINE DEHYDROGENASE - BIOCHEMICAL BASIS FOR FAMILIAL PYRIMIDINEMIA AND SEVERE 5-FLUOROURACIL-INDUCED TOXICITY [J].

DIASIO, RB ;

BEAVERS, TL ;

CARPENTER, JT .

JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) :47-51

[5] THE PURINE PATH TO CHEMOTHERAPY [J].

ELION, GB .

SCIENCE, 1989, 244 (4900) :41-47

[6] ALTERED MERCAPTOPURINE METABOLISM, TOXIC EFFECTS, AND DOSAGE REQUIREMENT IN A THIOPURINE METHYLTRANSFERASE-DEFICIENT CHILD WITH ACUTE LYMPHOCYTIC-LEUKEMIA [J].

EVANS, WE ;

HORNER, M ;

CHU, YQ ;

KALWINSKY, D ;

ROBERTS, WM .

JOURNAL OF PEDIATRICS, 1991, 119 (06) :985-989

[7] DIAGNOSTIC-ANALYSIS, CLINICAL IMPORTANCE AND MOLECULAR-BASIS OF DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY [J].

GONZALEZ, FJ ;

FERNANDEZSALGUERO, P .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (10) :325-327

[8] MOLECULAR-GENETICS OF THE N-ACETYLTRANSFERASES [J].

GRANT, DM .

PHARMACOGENETICS, 1993, 3 (01) :45-50

[9] Nm23-H1: Genetic alterations and expression patterns in tumor metastasis [J].

Hartsough, MT ;

Steeg, PS .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :6-10

[10] BENEFICIAL-EFFECTS OF CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE AFTER KIDNEY-TRANSPLANTATION [J].

HOLLANDER, AAMJ ;

VANSAASE, JLCM ;

KOOTTE, AMM ;

VANDORP, WT ;

VANBOCKEL, HJ ;

VANES, LA ;

VANDERWOUDE, FJ .

LANCET, 1995, 345 (8950) :610-614

← 1 2 3 4 →